miltefosine has been researched along with Skin Diseases in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine has been approved for oral and topical treatment of leishmaniasis and may also be a promising candidate for the topical treatment of Acanthamoeba infections." | 1.35 | Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. ( Auer, H; Duchêne, M; Gruber, F; Mildner, M; Obwaller, A; Suchomel, M; Tschachler, E; Walochnik, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walochnik, J | 1 |
| Obwaller, A | 1 |
| Gruber, F | 1 |
| Mildner, M | 1 |
| Tschachler, E | 1 |
| Suchomel, M | 1 |
| Duchêne, M | 1 |
| Auer, H | 1 |
1 other study available for miltefosine and Skin Diseases
| Article | Year |
|---|---|
Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent.
Topics: Acanthamoeba; Animals; Antiprotozoal Agents; Candida albicans; Drug Stability; Drug Storage; Humans; | 2009 |